Study of biomarkers in the epithelial-mesenchymal transition of triple negative breast cancers and their associations with clinicopathological parameters

Study of biomarkers in the epithelial-mesenchymal transition of triple negative breast cancers and their associations with clinicopathological parameters

Triple Negative Breast cancer (TNBC) is a newly studied subtype of breast cancer. Existing literature demonstrates that as cancer advances, the tumor cells will undergo epithelial-mesenchymal transition (EMT) to form secondary tumors at distant site. E-cadherin and Vimentin are biomarkers for epithe...

Saved in:

書目詳細資料
主要作者:	Chai, Xiu Hui
其他作者:	School of Biological Sciences
格式:	Final Year Project
語言:	English
出版:	2011
主題:	DRNTU::Science::Medicine::Biosensors
在線閱讀:	http://hdl.handle.net/10356/45029
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!
機構:	Nanyang Technological University
語言:	English

相似書籍

Study of tumor-associated macrophages in triple-negative breast cancer and their correlation with clinicopathological parameters
由: Priyalatha Kurusamy
出版: (2014)

Triple-negative breast cancer: Clinicopathological characteristics and relationship with basal-like breast cancer
由: Thike, A.A., et al.
出版: (2014)

Epithelial-Mesenchymal transition in Breast Cancer Progression
由: KELLY LIM SWEE YING
出版: (2010)

Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer
由: Zhou, L, et al.
出版: (2020)

Triple-negative Breast Cancer
由: Panuwat Lertsithichai
出版: (2022)

EPIGENETIC REGULATION OF CELL STATE TRANSITIONS IN TRIPLE NEGATIVE BREAST CANCER
由: TOH LI PING
出版: (2021)

Study of sFRP1 and β-catenin of Wnt signaling pathway in triple negative breast cancer and their correlation with clinicopathologic outcomes.
由: Seah, Cindy Chiou Peng.
出版: (2011)

Investigating functions of ERp29 in mesenchymal to epithelial transition (MET) and epithelial plasticity in breast cancer cells
由: I FON BAMBANG
出版: (2012)

Study of sFRP1 and cyclin D1 of Wnt signalling pathway in triple negative breast cancer and correlation with clinicopathologic outcomes.
由: Lee, Melody Wern Ling.
出版: (2011)

Distant metastasis in triple-negative breast cancer
由: Tseng, L.M., et al.
出版: (2016)

Wnt signaling in triple-negative breast cancer
由: Pohl, Sö.-G, et al.
出版: (2020)

Discovery of exosomes as gastric cancer biomarkers from conditioned cell culture media.
由: Low, Su Jun.
出版: (2011)

Regulome of cancer epithelial-mesenchymal transition (EMT)
由: See, Benedict
出版: (2020)

Epithelial-mesenchymal transitions in cancer onset and progression
由: Thiery, J.-P.
出版: (2014)

Submonolayer biolasers for ultrasensitive biomarker detection
由: Gong, Chaoyang, et al.
出版: (2024)

Disease-free Probability and Triple-Negative Breast Cancer
由: Prakasit Chirappapha, et al.
出版: (2022)

Halting triple negative breast cancer by targeting PROCR
由: Yang Fu, Nai, et al.
出版: (2020)

Clinicopathological study of biomarkers in prostrate cancer
由: TAN YEN
出版: (2012)

Cancer stem cell and epithelial�mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast
由: Oon, Ming Liang, et al.
出版: (2016)

Study metastatic properties of triple negative breast cancer cells.
由: Zhou, Yinning.
出版: (2013)

Targeting triple-negative breast cancer: Optimising therapeutic outcomes
由: Gelmon, K., et al.
出版: (2016)

Targeting pathways contributing to epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer
由: Huang, R.Y.-J., et al.
出版: (2014)

EFFECTS OF PLUMBAGIN ON CYTOTOXICITY, TAMOXIFEN SENSITIVITY AND EPITHELIAL-MESENCHYMAL TRANSITION-ASSOCIATED METASTASIS IN ENDOCRINE RESISTANT BREAST CANCER CELLS
由: Nueng Sakunrangsit
出版: (2014)

Development of SERS biosensor platforms for biomarker detection
由: Aw, Amelia Yun Yi
出版: (2018)

MicroRNA-138 is a prognostic biomarker for triple-negative breast cancer and promotes tumorigenesis via TUSC2 repression
由: Nama, Srikanth, et al.
出版: (2020)

MicroRNA-138 is a Prognostic Biomarker for Triple-Negative Breast Cancer and Promotes Tumorigenesis via TUSC2 repression
由: Nama, S., et al.
出版: (2022)

ANNEXIN-A1, A NOVEL BIOMARKER PREDICTS CHEMO-SENSITIVITY TO PPAR-¿ AGONIST THERAPY IN TRIPLE-NEGATIVE BREAST CANCER
由: CHEN LUXI
出版: (2013)

Versatile types of DNA-based nanobiosensors for specific detection of cancer biomarker FEN1 in living cells and cell-free systems
由: Zhang, Hao, et al.
出版: (2020)

Epigenetic regulation of epithelial–mesenchymal transition during cancer development
由: Yoodee S.
出版: (2023)

FOXQ1 regulates epithelial-mesenchymal transition in human cancers
由: Qiao, Y., et al.
出版: (2014)

Effect of gigantol on epithelial to mesenchymal transition in lung cancer cells
由: Thitita Unahabhokha
出版: (2015)

Generating a stable cell line of BT474-biosensor for tracking the metastasis of human breast cancer cells in animal models
由: Adhylakshumie Adhynarayanan
出版: (2011)

EZH2 AND FOXM1 CROSSTALK IN TRIPLE NEGATIVE BREAST CANCER
由: SYLVIA MAHARA
出版: (2016)

Clinicopathological significance of metallothioneins in breast cancer
由: Jin, R., et al.
出版: (2012)

STRUCTURAL ENGINEERING OF TRANSITION METAL DICHALCOGENIDES FOR METABOLIC BIOMARKERS PROFILING IN EXTRACELLULAR VESICLES
由: CHEN QINGCHANG
出版: (2023)

MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression
由: Kong, X., et al.
出版: (2014)

Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120)
由: Huang, R.Y.-J, et al.
出版: (2020)

Mechanoregulation of angiopoietin-like 4 in epithelial-mesenchymal transition and cancer metastasis
由: Liao, Zehuan
出版: (2024)

Expression of FGFR1 is an independent prognostic factor in triple-negative breast cancer
由: Cheng, Cheeleong, et al.
出版: (2016)

Triple negative breast cancer: Outcome correlation with immunohistochemical detection of basal markers
由: Thike, A.A., et al.
出版: (2014)